These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6619271

  • 1. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD, Peters JR, Foord SM, Dieguez C, Edwards C, Gomez-Pan A, Hall R, Newcombe RG, Scanlon MF.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [Abstract] [Full Text] [Related]

  • 2. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
    Larrea F, Escorza A, Valencia X, Méndez I, Schiavon R, Forsbach G.
    Rev Invest Clin; 1991 Nov; 43(4):293-8. PubMed ID: 1798861
    [Abstract] [Full Text] [Related]

  • 3. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF, Rodriguez-Arnao MD, McGregor AM, Weightman D, Lewis M, Cook DB, Gomez-Pan A, Hall R.
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
    Peters JR, Rodriguez-Arnao MD, Foord SM, Edwards C, Dieguez C, Woodhead S, Hall R, Scanlon MF.
    J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
    Coiro V, Butturini U, Gnudi A, Volpi R, d'Amato L, Speroni G, Capretti L, Roti E, Chiodera P.
    Horm Res; 1987 Apr; 25(4):206-14. PubMed ID: 3108134
    [Abstract] [Full Text] [Related]

  • 15. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM, Peters JR, Dieguez C, Scanlon MF, Hall R.
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition.
    Nicoletti I, Filipponi P, Fedeli L, Gregorini G, Ambrosi F, Sfrappini M, Santeusanio F, Brunetti P.
    Horm Metab Res; 1984 Dec; 16(12):658-62. PubMed ID: 6441763
    [Abstract] [Full Text] [Related]

  • 18. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
    Prescott RW, Johnston DG, Taylor PK, Haigh J, Weightman DR, Hall K, Cook DB.
    J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.